Stockreport

Novartis Price Fixing, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

DURECT Corporation  (DRRX) 
Last durect corporation earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: durect.com/investors
PDF Summary Novartis agrees to pay in settlement for its subsidiary Sandoz' price fixing issue. Durect reports results. Centene tanks on guidance. Centene Provides Guidance [Read more]